Conferences - Results from #11340

AUA 2013 - Session Highlights: Surveillance of renal function after (partial) tumor nephrectomy by cystatin C-measurement May 6, 2013

AUA 2013 - Session Highlights: Salvage radiation therapy after recurrent prostate cancer: How early do we need to be? May 6, 2013

AUA 2013 - Session Highlights: Head-to-head comparison between nomograms and multiparametric MRI to predict side specific extra capsular extension to indicate nerve sparing during radical prostatectomy May 6, 2013

AUA 2013 - Session Highlights: Should staging transrectal saturation biopsy be a standard for assessment of disease progression and follow up for prostate cancer patients on active surveillance? May 6, 2013

AUA 2013 - Session Highlights: Pain and quality of life (QoL) analyses from the phase 3 randomized ALSYMPCA study with radium-223 dichloride (Ra-223) in castration-resistant prostate cancer (CRPC) patients with bone metastases May 6, 2013

Evidence supports efficacy of enzyme in treatment of Peyronie's disease May 6, 2013

AUA 2013 - Poster: Composite responders showed improvement in both penile curvature deformity and symptom bother in two large double-blind, randomized, placebo-controlled phase 3 studies of collagenase clostridium histolyticum in the treatment of Peyronie May 6, 2013

AUA releases new guidelines for treating castration-resistant prostate cancer May 6, 2013

AUA 2013 - Slide Presentation: Castration-resistant prostate cancer (CRPC): AUA Guideline May 6, 2013

AUA 2013 - Session Highlights: Salvage Palladium brachytherapy for local failure after initial external radiotherapy for prostate cancer May 6, 2013

AUA 2013 - Slide Presentation: Composite responders showed improvement in both penile curvature deformity and symptom bother in two large double-blind, randomized, placebo-controlled phase 3 studies of collagenase clostridium histolyticum in the treatment May 6, 2013

AUA 2013 - Session Highlights: The impact of multiple biopsies on erectile and voiding function after radical prostatectomy: A population-based assessment May 6, 2013

AUA 2013 - Slide Presentation: ZYTIGA® (abiraterone acetate): Introducing a new option for patients with mCRPC before chemotherapy May 6, 2013

AUA 2013 - Session Highlights: Determination of the accuracy of FDG-PET/CT in the primary staging of biological high-risk prostate cancers before local therapies: Increased uptake associated with highly aggressive tumors May 6, 2013

AUA 2013 - Poster: Tumor contour “irregularity” predicts high grade pathology in large renal masses May 5, 2013

AUA 2013 - Poster: Does adherence to candidate quality measures for muscle invasive bladder cancer vary by hospital type? May 5, 2013

AUA 2013 - Poster: Neoadjuvant accelerated MVAC (AMVAC) in patients with muscle invasive bladder cancer: A multi-institutional prospectively accrued cohort May 5, 2013

AUA 2013 - Slide Presentation: Detection of Prostate Cancer: AUA Guideline May 5, 2013

AUA 2013 - Podcast: AUA 2013 prostate cancer detection clinical guidelines May 5, 2013

AUA 2013 - Session Highlights: The metastatic potential of retroperitoneal tumors: Analysis and comparison of renal cell carcinoma (RCC), adrenocortical carcinoma (ACC), and retroperitoneal sarcoma (RPS) cohorts from the National Cancer Data Base (NCDB) May 4, 2013

Page 568 of 594